MG-S-2525
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Metagone Biotech Inc.
Overview
MG-S-2525 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
MG-S-2525 clinical trials
Explore related
Medical disclaimer. This page summarizes research about MG-S-2525 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.